Google-backed AI-developed drugs are headed to trial by 2026, says DeepMind CEO

Google-backed AI-developed drugs are headed to trial by 2026, says DeepMind CEO

In This Story

Drugs developed by Alphabet’s drug discovery subsidiary and designed by artificial intelligence are expected to head to trial by the end of the year, according to a Google (GOOGL) executive.

Article Source
https://qz.com/google-ai-designed-drugs-deepmind-isomorphic-insilico-1851745806

More From Author

VMware users unhappy at 3-year commitment to renew licenses

VMware users unhappy at 3-year commitment to renew licenses

Cisco Outlines Its “Internet of Agents” Vision

Cisco Outlines Its “Internet of Agents” Vision

Listen to the Podcast Overview

Watch the Keynote